Basic Information
| RNALocate ID: | RLID:11001314 |
| RNA Symbol: | hsa-miR-129-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-129-5p |
| RNA ID: | miRBase:MIMAT0000242 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11001311 | Exosome | Jurkat-derived T cell line (J77cl20) | 21505438 |
| RLID:11001312 | Exosome | Renal cancer cells | 21670082 |
| RLID:11001313 | Exosome | Brain tissue | 23382797 |
| RLID:11001315 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11001316 | Microvesicle | Cerebrospinal fluid | 24797360 |
| RLID-D:11000040 | Exosome | Blood | |
| RLID-D:11000309 | Microvesicle | Blood|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-129-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-09946 |
| MNDR | hsa-miR-129-5p | Medulloblastoma | MNDR-E-MI-09947 |
| MNDR | hsa-miR-129-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-09948 |
| MNDR | hsa-miR-129-5p | Autism spectrum disorder | MNDR-E-MI-09949 |
| MNDR | hsa-miR-129-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-09950 |
| MNDR | hsa-miR-129-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-09951 |
| MNDR | hsa-miR-129-5p | Triple negative breast cancer | MNDR-E-MI-09952 |
| MNDR | hsa-miR-129-5p | Breast cancer luminal | MNDR-E-MI-09953 |
| MNDR | hsa-miR-129-5p | Small intestine cancer | MNDR-E-MI-09954 |
| MNDR | hsa-miR-129-5p | Prostate cancer | MNDR-E-MI-09955 |
| MNDR | hsa-miR-129-5p | Gastric cancer | MNDR-E-MI-09956 |
| MNDR | hsa-miR-129-5p | Alzheimer disease | MNDR-E-MI-09957 |
| MNDR | hsa-miR-129-5p | Bladder cancer | MNDR-E-MI-09958 |
| MNDR | hsa-miR-129-5p | Esophageal carcinoma | MNDR-E-MI-09959 |
| MNDR | hsa-miR-129-5p | Primary biliary cirrhosis | MNDR-E-MI-09960 |
| MNDR | hsa-miR-129-5p | Huntington disease | MNDR-E-MI-09961 |
| MNDR | hsa-miR-129-5p | Chorea | MNDR-E-MI-09962 |
| MNDR | hsa-miR-129-5p | Cardiovascular disease | MNDR-E-MI-09963 |
| MNDR | hsa-miR-129-5p | Lung cancer | MNDR-E-MI-09964 |
| MNDR | hsa-miR-129-5p | Endometrial cancer | MNDR-E-MI-09965 |
| MNDR | hsa-miR-129-5p | Fragile x syndrome | MNDR-E-MI-09966 |
| MNDR | hsa-miR-129-5p | Parkinson disease | MNDR-E-MI-09967 |
| MNDR | hsa-miR-129-5p | Breast cancer | MNDR-E-MI-09968 |
| MNDR | hsa-miR-129-5p | Thyroid cancer | MNDR-E-MI-09969 |
| MNDR | hsa-miR-129-5p | Pituitary neoplasms | MNDR-E-MI-09970 |
| MNDR | hsa-miR-129-5p | Pancreatic cancer | MNDR-E-MI-09971 |
| MNDR | hsa-miR-129-5p | Malignant melanoma | MNDR-E-MI-09972 |
| MNDR | hsa-miR-129-5p | Rectum adenocarcinoma | MNDR-E-MI-09973 |
| MNDR | hsa-miR-129-5p | Nephroblastoma | MNDR-E-MI-09974 |
| MNDR | hsa-miR-129-5p | Colon cancer | MNDR-E-MI-09975 |
| MNDR | hsa-miR-129-5p | Colon adenocarcinoma | MNDR-E-MI-09976 |
| MNDR | hsa-miR-129-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-09977 |
| MNDR | hsa-miR-129-5p | Familial ovarian cancer | MNDR-E-MI-09978 |
| MNDR | hsa-miR-129-5p | Prostate adenocarcinoma | MNDR-E-MI-09979 |
| MNDR | hsa-miR-129-5p | Laryngeal squamous cell carcinoma | MNDR-E-MI-09980 |
| MNDR | hsa-miR-129-5p | Carcinoma ductal breast | MNDR-E-MI-09981 |
| MNDR | hsa-miR-129-5p | Glioblastoma | MNDR-E-MI-09982 |
| MNDR | hsa-miR-129-5p | Astrocytoma | MNDR-E-MI-09983 |
| MNDR | hsa-miR-129-5p | Glioma | MNDR-E-MI-09984 |
| MNDR | hsa-miR-129-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-09985 |
| MNDR | hsa-miR-129-5p | Epilepsy temporal lobe | MNDR-E-MI-09986 |
| MNDR | hsa-miR-129-5p | Osteosarcoma | MNDR-E-MI-09987 |
| MNDR | hsa-miR-129-5p | Chondrosarcoma | MNDR-E-MI-09988 |
| MNDR | hsa-miR-129-5p | Gastric adenocarcinoma | MNDR-E-MI-09989 |
| MNDR | hsa-miR-129-5p | Cervical squamous cell carcinoma | MNDR-E-MI-09990 |
| MNDR | hsa-miR-129-5p | Lung squamous cell carcinoma | MNDR-E-MI-09991 |
| MNDR | hsa-miR-129-5p | Non-small cell lung cancer | MNDR-E-MI-09992 |
| MNDR | hsa-miR-129-5p | Lung adenocarcinoma | MNDR-E-MI-09993 |
| MNDR | hsa-miR-129-5p | Thyroid carcinoma | MNDR-E-MI-09994 |
| MNDR | hsa-miR-129-5p | Medullary thyroid carcinoma | MNDR-E-MI-09995 |
| MNDR | hsa-miR-129-5p | Thyroid medullary carcinoma | MNDR-E-MI-09996 |
| MNDR | hsa-miR-129-5p | Bladder urothelial carcinoma | MNDR-E-MI-09997 |
| MNDR | hsa-miR-129-5p | Pancreatic adenocarcinoma | MNDR-E-MI-09998 |
| MNDR | hsa-miR-129-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-09999 |
| MNDR | hsa-miR-129-5p | Kidney renal clear cell carcinoma | MNDR-E-MI-10000 |
| MNDR | hsa-miR-129-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-10001 |
| MNDR | hsa-miR-129-5p | Clear cell renal cell carcinoma | MNDR-E-MI-10002 |
| MNDR | hsa-miR-129-5p | Cholangiocarcinoma | MNDR-E-MI-10003 |
| MNDR | hsa-miR-129-5p | Lung small cell carcinoma | MNDR-E-MI-10004 |
| MNDR | hsa-miR-129-5p | Breast invasive carcinoma | MNDR-E-MI-10005 |
| MNDR | hsa-miR-129-5p | Hepatocellular carcinoma | MNDR-E-MI-10006 |
| MNDR | hsa-miR-129-5p | Familiar ovarian carcinoma | MNDR-E-MI-10007 |
| MNDR | hsa-miR-129-5p | B-cell lymphoma | MNDR-E-MI-10008 |
| MNDR | hsa-miR-129-5p | Malignant pleural mesothelioma | MNDR-E-MI-10009 |
| MNDR | hsa-miR-129-5p | Hodgkin lymphoma | MNDR-E-MI-10010 |
| MNDR | hsa-miR-129-5p | Burkitt lymphoma | MNDR-E-MI-10011 |
| MNDR | hsa-miR-129-5p | Tonsil cancer | MNDR-E-MI-10012 |
| MNDR | hsa-miR-129-5p | Colorectal cancer | MNDR-E-MI-10013 |
| MNDR | hsa-miR-129-5p | Nasopharynx carcinoma | MNDR-E-MI-10014 |
| MNDR | hsa-miR-129-5p | Ependymoma | MNDR-E-MI-10015 |
| MNDR | hsa-miR-129-5p | Nasopharyngeal cancer | MNDR-E-MI-10016 |
| MNDR | hsa-miR-129-5p | AIDS dementia complex | MNDR-E-MI-10017 |
| MNDR | hsa-miR-129-5p | Stroke lacunar | MNDR-E-MI-10018 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCB1 | Homo sapiens | RR00022773 |
TOP